Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-03-26 / Oncoimmunology 2018;7(7):e1445457Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2018-03-26 / J Immunol Res 2018;2018:8740976Dendritic cells as cancer therapeutics
/in Dendritic Cells, International Publications /von 2018-03-21 / Semin. Cell Dev. Biol. 2019 Feb;86:77-88Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-03-18 / J Immunol Res 2018;2018:3982942Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2018-03-08 / Exp Ther Med 2018 May;15(5):4522-4530Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-03-06 / J Immunother Cancer 2018 Mar;6(1):19PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease Virus /von 2018-03-05 / J. Clin. Invest. 2018 Apr;128(4):1413-1428Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2018-03-01 / Front Immunol 2018;9:394
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution